Period loss, or amenorrhea, affects approximately 3% to 4% of women of reproductive age. It can be the body’s response to an ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the ...

DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

Inavolisib (Itovebi) is a new targeted therapy for HR+ HER2-negative metastatic breast cancer with a PIK3CA mutation.

Cambridge researchers are working to undo a longstanding male bias in health research, to help drive more effective ...

The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of ...

The ASCENT-03 trial is a phase 3 study assessing the efficacy and safety of sacituzumab govitecan compared with physician’s choice of treatment in patients with previously untreated, locally advanced, ...

Our medical system is broken. Could the answer lie in exposure to subfreezing temperatures and depriving our bodies of oxygen?

W e need to discuss the switch up that comes with aging and “second puberty” in your 20s. After the hormonal chaos of teenage years, you would think we could catch a break. Bu ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- What Does The Data On The Alopecia Treatment Market Size Indicate? Driven by an increasing prevalence of hair loss and ...

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...